» Articles » PMID: 18958627

Distress Persists in Long-term Brain Tumor Survivors with Glioblastoma Multiforme

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2008 Oct 30
PMID 18958627
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor. The prognosis for GBM patients is extremely poor with an estimated median survival of 12 months. Despite this statistic, a number of GBM patients are living longer than in the past as new detection and treatment approaches are used. However, little is known about the psychological correlates of this disease. To address this issue we investigated distress and its sources in long-term survivors (LTS) of this disease.

Materials And Methods: Participants were asked to complete the National Comprehensive Cancer Network's (NCCN) Distress Thermometer, a single-item rapid screening tool for distress. Participants were also asked to designate sources of distress from a 34-item list developed by the NCCN. Distress scores and sources of distress for long-term GBM survivors (>18 months) were compared to patients diagnosed within the last 18 months (<18 months).

Results: Eight-three brain tumor patients participated in this study. Fifty-nine percent of LTS met the > or = 4 cut-off score for distress (M = 4.61, SD 3.12) as compared to 49% of patients diagnosed less than 18 months (M = 3.93, SD = 2.21; x(2) = 0.406, NS), LTS reported fewer items of concern while more LTS reported being distressed.

Conclusions: This study indicates that LTS of GBM report experiencing distress at similar levels to other brain tumor patients. Level of distress for LTS is directly related to the total number of concerns in both emotional and physical domains.

Implications For Cancer Survivors: Regardless of LTS status, distress continues to be a part of the disease trajectory for many GBM patients. As such, attention to distress in these survivors of a major life threatening disease is warranted in follow up surveillance visits.

Citing Articles

Brain tumor-related epilepsy: an overview on neuropsychological, behavioral, and quality of life issues and assessment methodology.

Maschio M, Perversi F, Maialetti A Front Neurol. 2024; 15:1480900.

PMID: 39722690 PMC: 11668670. DOI: 10.3389/fneur.2024.1480900.


Increased Distress in Neurooncological Patients, a Monocentric Longitudinal Study: When to Screen Which Patient?.

Staub-Bartelt F, Steinmann J, Wienand M, Sabel M, Rapp M Diseases. 2024; 12(9).

PMID: 39329886 PMC: 11431417. DOI: 10.3390/diseases12090217.


Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a systematic review of what neurosurgeons need to know.

Young J, Al-Adli N, Sibih Y, Scotford K, Casey M, James S J Neurosurg. 2022; 139(1):11-19.

PMID: 36334288 PMC: 10413205. DOI: 10.3171/2022.9.JNS221139.


Classical and disease-specific quality indicators in glioma surgery-Development of a quality checklist to improve treatment quality in glioma patients.

Menke C, Lohmann S, Baehr A, Grauer O, Holling M, Brokinkel B Neurooncol Pract. 2022; 9(1):59-67.

PMID: 35096404 PMC: 8789264. DOI: 10.1093/nop/npab063.


A cross-sectional audit of distress in patients undergoing adjuvant therapy or follow-up in central nervous system malignancies.

Patil V, Malhotra M, Tonse R, Deodhar J, Chandrasekharan A, Pande N Neurooncol Pract. 2019; 6(4):305-310.

PMID: 31386081 PMC: 6660816. DOI: 10.1093/nop/npy046.


References
1.
Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M . Long-term survival with glioblastoma multiforme. Brain. 2007; 130(Pt 10):2596-606. DOI: 10.1093/brain/awm204. View

2.
Ozols R, Herbst R, Colson Y, Gralow J, Bonner J, Curran Jr W . Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol. 2006; 25(1):146-62. DOI: 10.1200/JCO.2006.09.7030. View

3.
Trask P, Paterson A, Riba M, Brines B, Griffith K, Parker P . Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant. 2002; 29(11):917-25. DOI: 10.1038/sj.bmt.1703557. View

4.
DeAngelis L . Brain tumors. N Engl J Med. 2001; 344(2):114-23. DOI: 10.1056/NEJM200101113440207. View

5.
Bosma I, Vos M, Heimans J, Taphoorn M, Aaronson N, Postma T . The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol. 2006; 9(1):53-62. PMC: 1828106. DOI: 10.1215/15228517-2006-012. View